strengthenfda.org
Alliance Learns About CBER Priorities for 2020 and Beyond
At the Alliance’s request, Dr. Peter Marks, Director of FDA’s Center for Biologics Evaluation and Research, met with Alliance members this week to discuss opportunities, challenges and priorities a…